Lab21 expands international business with launch into India

  • Posted on 11 November 2008

Lab21’s immunodiagnostic division has entered into a substantial distribution agreement with Inverness Medical India (Spectral Diagnostics Pvt. Ltd) to supply more than 500,000 TPHA kits for the diagnosis of syphilis.

This initial contract will see approximately $1.1 million of reagents supplied into the Indian healthcare market over the next 18 months.

  • Share this article
  • Got more on this story? Email PharmaAsia